These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 350429)
1. [Experience with prophylactic medical care of vesiculobullous diseases (author's transl)]. Rozsívalová V Cesk Dermatol; 1978 Jan; 53(1):40-4. PubMed ID: 350429 [No Abstract] [Full Text] [Related]
2. When and how to use sulfones in bullous diseases. Jablonska S; Chorzelski T Int J Dermatol; 1981 Mar; 20(2):103-5. PubMed ID: 7012048 [No Abstract] [Full Text] [Related]
4. Autoimmune bullous dermatoses: a review. Patrício P; Ferreira C; Gomes MM; Filipe P Ann N Y Acad Sci; 2009 Sep; 1173():203-10. PubMed ID: 19758152 [TBL] [Abstract][Full Text] [Related]
6. [Pemphigus and pemphigoid]. Stewart WM Dermatologica; 1980; 160(4):217-35. PubMed ID: 6987108 [TBL] [Abstract][Full Text] [Related]
7. [Therapy of pemphigus and pemphigoid]. Schaumburg-Lever G Z Hautkr; 1986 Jun; 61(11):811-2. PubMed ID: 3526731 [TBL] [Abstract][Full Text] [Related]
8. Evaluation and management of diseases of the vulva: bullous diseases. Lim HW; Bystryn JC Clin Obstet Gynecol; 1978 Dec; 21(4):1007-22. PubMed ID: 367668 [No Abstract] [Full Text] [Related]
9. Autoimmune bullous dermatoses: a review. Bickle K; Roark TR; Hsu S Am Fam Physician; 2002 May; 65(9):1861-70. PubMed ID: 12018809 [TBL] [Abstract][Full Text] [Related]
10. [Complications of sulphone treatment in dermatitis herpetiformis Duhring (author's transl)]. Rozsívalová V; Komárková O Cesk Dermatol; 1976 Feb; 51(1):44-8. PubMed ID: 1260873 [No Abstract] [Full Text] [Related]
11. Pemphigus and pemphigoid: dermatologic examples of type II immune reactivity. Sams WM Ann Allergy; 1976 Oct; 37(4):255-63. PubMed ID: 791025 [TBL] [Abstract][Full Text] [Related]
12. [Immunofluorescence and immunoperoxidase: a comparison for sensitivity in cutaneous immunopathology (author's transl)]. Zanin LG; Schmitt D; Ohrt C; Thivolet J Ann Dermatol Venereol; 1978 Oct; 105(10):793-8. PubMed ID: 371495 [TBL] [Abstract][Full Text] [Related]
14. Failure of isotretinoin to control dermatitis herpetiformis and subcorneal pustular dermatosis. Rutman AJ; Powles AV; Griffiths CE; McFadden J; Fry L Br J Dermatol; 1988 Aug; 119(2):270-1. PubMed ID: 3048371 [No Abstract] [Full Text] [Related]
15. Bullous rheumatoid neutrophilic dermatosis. Kreuter A; Rose C; Zillikens D; Altmeyer P J Am Acad Dermatol; 2005 May; 52(5):916-8. PubMed ID: 15858492 [No Abstract] [Full Text] [Related]
16. [Personal experience with methotrexate in the treatment of various bullous diseases (Duhring-Brocq, pemphigus)]. Basset A; Bergoend H; Grosshans E; Heid E; Maleville J Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):371-6. PubMed ID: 5510728 [No Abstract] [Full Text] [Related]
17. [Contribution to the problem of pemphigus--dermatitis herpetiformis]. Rozsĭvalovă V Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1966; 9(1):Suppl:195-211. PubMed ID: 4168039 [No Abstract] [Full Text] [Related]
18. [Remote results of the treatment of patients with chronic pemphigus and Duhring's dermatitis herpetiformis]. Nizar AD Vestn Dermatol Venerol; 1970 Mar; 44(3):17-20. PubMed ID: 5469502 [No Abstract] [Full Text] [Related]
19. [Dispensary observation of patients with subcorneal pustulosis (Sneddon-Wilkinson disease) and their treatment]. Fetisova LP; Shakhnes IE Vestn Dermatol Venerol; 1978 Sep; (9):56-8. PubMed ID: 706747 [No Abstract] [Full Text] [Related]